These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22533488)

  • 21. Results of synovectomy of the knee in haemophilia.
    Bussi L; Silvello L; Baudo F; De Cataldo F
    Haematologica; 1974 Mar; 59(1):81-5. PubMed ID: 4213361
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synovectomy in the treatment of hemophilic arthropathy. (Clinico-hematological observations on a case of hemophilia B)].
    Signorelli S; De Maria A; Cacciola E
    Haematologica; 1971; 56(11):436-46. PubMed ID: 5004750
    [No Abstract]   [Full Text] [Related]  

  • 23. Tissue factor pathway inhibitor is the main determinant of thrombin generation in haemophilic patients.
    Chelle P; Montmartin A; Damien P; Piot M; Cournil M; Lienhart A; Genre-Volot F; Chambost H; Morin C; Tardy-Poncet B
    Haemophilia; 2019 Mar; 25(2):343-348. PubMed ID: 30690836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding haemophilic arthropathy: an exploration of current open issues.
    Jansen NW; Roosendaal G; Lafeber FP
    Br J Haematol; 2008 Dec; 143(5):632-40. PubMed ID: 18950457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania.
    Saulyte Trakymiene S; Ingerslev J; Rageliene L
    Haemophilia; 2010 May; 16(3):479-86. PubMed ID: 20070384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues.
    Bajaj MS; Kuppuswamy MN; Manepalli AN; Bajaj SP
    Thromb Haemost; 1999 Sep; 82(3):1047-52. PubMed ID: 10494762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the pathology of haemophilic joints.
    Storti E; Piovella F; Castello A; Ascari E
    Pathol Eur; 1974; 9(3):199-210. PubMed ID: 4453429
    [No Abstract]   [Full Text] [Related]  

  • 28. Haemophilia in Poland.
    Windyga J; Lopaciuk S; Stefanska E; Juszynski A; Wozniak D; Strzelecki O; Szczepanik AB
    Haemophilia; 2006 Jan; 12(1):52-7. PubMed ID: 16409175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of haemophilic synovitis: experimental studies on blood-induced joint damage.
    Valentino LA; Hakobyan N; Rodriguez N; Hoots WK
    Haemophilia; 2007 Nov; 13 Suppl 3():10-3. PubMed ID: 17822515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis.
    Conway EM; Nowakowski B
    Blood; 1993 Feb; 81(3):726-33. PubMed ID: 7678998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arthroscopic synovectomy in the treatment of haemophilic arthropathy: preliminary results in eight patients.
    Poggini L; Chistolini A; Mariani G; Mariani PP
    Ital J Orthop Traumatol; 1989 Dec; 15(4):457-61. PubMed ID: 2634638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombomodulin levels in the plasma and joint fluid from patients with rheumatoid arthritis.
    Ichikawa Y; Takaya M; Shimizu H; Moriuchi J; Uchiyama M; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):123-6. PubMed ID: 7701524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs.
    Brinkmann T; Kähnert H; Prohaska W; Nordfang O; Kleesiek K
    Eur J Clin Chem Clin Biochem; 1994 Apr; 32(4):313-7. PubMed ID: 7518699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of the orthopaedic complications of haemophilia.
    Rodríguez-Merchán EC
    J Bone Joint Surg Br; 1998 Mar; 80(2):191-6. PubMed ID: 9546442
    [No Abstract]   [Full Text] [Related]  

  • 36. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of bleeds on the development of arthropathy - basic and applied issues.
    van Vulpen LFD; Mastbergen SC; Lafeber FPJG; Schutgens REG
    Haemophilia; 2017 Jul; 23(4):521-527. PubMed ID: 28429865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells.
    Tarr JM; Winyard PG; Ryan B; Harries LW; Haigh R; Viner N; Eggleton P
    Arthritis Rheum; 2010 Oct; 62(10):2919-29. PubMed ID: 20533543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercalciuria in children with haemophilia suggests primary skeletal pathology.
    Ranta S; Viljakainen H; Mäkipernaa A; Mäkitie O
    Br J Haematol; 2011 May; 153(3):364-71. PubMed ID: 21391975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain and functional limitations in patients with severe haemophilia.
    van Genderen FR; Fischer K; Heijnen L; de Kleijn P; van den Berg HM; Helders PJ; van Meeteren NL
    Haemophilia; 2006 Mar; 12(2):147-53. PubMed ID: 16476089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.